Literature DB >> 3924218

Complications of ileal conduit diversion in adults with cancer followed up for at least five years.

D E Neal.   

Abstract

A total of 111 adults with malignant disease of the bladder were studied to determine the long term complications of ileal conduit diversion. Each patient had survived at least five years (mean 10 years) after cystectomy. At final follow up the radiological appearance of one or both kidneys had deteriorated in 50 (47%) of 107 patients: deterioration worsened significantly (p less than 0.01) with increasing duration of follow up. Eighteen patients (16%) developed biochemical evidence of impaired renal function, of whom four died of complications of renal failure. Bilateral upper tract dilatation was noted in 30 patients (28%), and in 21 its cause was obscure. Ten patients formed renal stones, and an additional 12 required further operations on the conduit or stoma. Despite the age of patients with bladder cancer and the poor prognosis of those with invasive tumours clinically important side effects were observed in a significant proportion of the long term survivors. Further efforts to determine the aetiology of upper tract dilatation in patients with an ileal conduit diversion are justified.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924218      PMCID: PMC1416098          DOI: 10.1136/bmj.290.6483.1695

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  Five years' experience with uretero-enterostomy by the combined technique.

Authors:  W F LEADBETTER; B G CLARKE
Journal:  J Urol       Date:  1955-01       Impact factor: 7.450

2.  A 20-year experience with ileal conduits: the fate of the kidneys.

Authors:  W R Pitts; E C Muecke
Journal:  J Urol       Date:  1979-08       Impact factor: 7.450

3.  The stoma of the ileal conduit.

Authors:  A B McEwan; P Clark
Journal:  Br J Urol       Date:  1973-12

4.  Urinary diversion in children.

Authors:  J E Scott
Journal:  Arch Dis Child       Date:  1973-03       Impact factor: 3.791

5.  Urinary diversion by ileal conduit. A long-term follow-up.

Authors:  A Kafetsioulis; J Swinney
Journal:  Br J Urol       Date:  1968-02

6.  Ureteric diversion using a conduit: a simplified technique.

Authors:  D M Wallace
Journal:  Br J Urol       Date:  1966-10

7.  Uretero-ileostomy.

Authors:  D M Wallace
Journal:  Br J Urol       Date:  1970-10

8.  The long-term results of ileal conduit urinary diversion in children.

Authors:  M Dunn; J B Roberts; P J Smith; N Slade
Journal:  Br J Urol       Date:  1979-12

9.  Combined surgery and adjuvant chemotherapy with high dose methotrexate and folinic acid rescue (HDMTX-CF) for infiltrating tumours of the bladder.

Authors:  Y Socquet
Journal:  Br J Urol       Date:  1981-10

10.  Long-term results of ileal conduit diversion in children--a brighter picture?

Authors:  A G Graham
Journal:  Br J Urol       Date:  1982-12
View more
  4 in total

Review 1.  Complications associated with urinary diversion.

Authors:  Richard E Hautmann; Stefan H Hautmann; Oliver Hautmann
Journal:  Nat Rev Urol       Date:  2011-11-01       Impact factor: 14.432

Review 2.  [Urinary diversions: which one one is right for which patient?].

Authors:  P Bader; D Westermann; D Frohneberg
Journal:  Urologe A       Date:  2009-02       Impact factor: 0.639

3.  Chronic kidney disease in patients with ileal conduit urinary diversion.

Authors:  Toshihide Naganuma; Yoshiaki Takemoto; Satoshi Maeda; Tomoaki Iwai; Nobuyuki Kuwabara; Tetsuo Shoji; Mikio Okamura; Tatsuya Nakatani
Journal:  Exp Ther Med       Date:  2012-09-11       Impact factor: 2.447

4.  Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB).

Authors:  Salvatore Siracusano; Mauro Niero; Cristina Lonardi; Maria Angela Cerruto; Stefano Ciciliato; Laura Toffoli; Francesco Visalli; Davide Massidda; Massimo Iafrate; Walter Artibani; Pierfrancesco Bassi; Ciro Imbimbo; Marco Racioppi; Renato Talamini; Carolina D'Elia; Giovanni Cacciamani; Davide De Marchi; Tommaso Silvestri; Paolo Verze; Emanuele Belgrano
Journal:  Health Qual Life Outcomes       Date:  2014-09-01       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.